Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ravdin, P. M.
Right arrow Articles by Harvey, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ravdin, P. M.
Right arrow Articles by Harvey, J. A.

Journal of Clinical Oncology, Vol 16, 515-521, Copyright © 1998 by American Society of Clinical Oncology

ARTICLES

Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy

PM Ravdin, IA Siminoff and JA Harvey
University of Texas Health Science Center, San Antonio 78284-7884, USA. ravdin@uthscsa.edu

PURPOSE: A survey of breast cancer survivors in the United States was conducted to define what they had been told about their prognosis and the value of adjuvant therapy, what they estimated their prognosis to be with and without adjuvant therapy, and what level of improvement they would have found minimally worthwhile. MATERIALS AND METHODS: Survey questionnaires were mailed to individual members and member organizations of the National Alliance of Breast Cancer Organizations (NABCO). Questionnaires were returned anonymously in prepaid mailers. Five hundred sixty-two women responded. Of these, the 318 women who received adjuvant chemotherapy were included in this analysis. RESULTS: Only 39% of the women recalled receiving quantitative estimates of their prognosis, and only 31% of women received a quantitative estimate both with and without adjuvant therapy. Sixty-eight percent of the women were able to provide a quantitative estimate for their outcome at 5 years both with and without adjuvant therapy. From these estimates, we calculated that the median estimated proportional risk reduction for recurrence that women thought they had achieved was 79%. Women were asked what degree of absolute benefit they would have found acceptable. The median acceptable extension of life expectancy was 3 to 6 months, and acceptable reduction in recurrence risk was 0.5% to 1.0%. However, there was considerable variation, with 27% of women not accepting less than 1 year and 26% not accepting a less than 5% reduction in recurrence risk. CONCLUSION: In general, American women in the surveyed population (1) do not recall being provided quantitative estimates of outcome during the process of making decisions about adjuvant therapy, (2) overestimate the value of their therapy, and (3) often will accept remarkably low degrees of net benefit. Overall, these observations can be used to support the argument that improvements in doctor/patient communication may be important to truly informed decision-making, and that flexibility for individual patients' preferences should not be superseded by rigid treatment guidelines.


This article has been cited by other articles:


Home page
 JCOHome page
A. H. Partridge
Fertility Preservation: A Vital Survivorship Issue for Young Women With Breast Cancer
J. Clin. Oncol., June 1, 2008; 26(16): 2612 - 2613.
[Full Text] [PDF]

Home page
 JCOHome page
S. C. O'Neill, N. T. Brewer, S. E. Lillie, E. F. Morrill, E. C. Dees, L. A. Carey, and B. K. Rimer
Women's Interest in Gene Expression Analysis for Breast Cancer Recurrence Risk
J. Clin. Oncol., October 10, 2007; 25(29): 4628 - 4634.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. E. Lillie, N. T. Brewer, S. C. O'Neill, E. F. Morrill, E. C. Dees, L. A. Carey, and B. K. Rimer
Retention and Use of Breast Cancer Recurrence Risk Information from Genomic Tests: The Role of Health Literacy
Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 249 - 255.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. Pusztai
Chips to Bedside: Incorporation of Microarray Data into Clinical Practice
Clin. Cancer Res., December 15, 2006; 12(24): 7209 - 7214.
[Full Text] [PDF]

Home page
 The OncologistHome page
S. Burdette-Radoux and H. B. Muss
Adjuvant chemotherapy in the elderly: whom to treat, what regimen?
Oncologist, March 1, 2006; 11(3): 234 - 242.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
V. M. Duric, M. R. Stockler, S. Heritier, F. Boyle, J. Beith, A. Sullivan, N. Wilcken, A. S. Coates, and R. J. Simes
Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?
Ann. Onc., November 1, 2005; 16(11): 1786 - 1794.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S.J.T. Jansen, W. Otten, M.C.M. Baas-Thijssen, C.J.H. van de Velde, J.W.R. Nortier, and A.M. Stiggelbout
Explaining Differences in Attitude Toward Adjuvant Chemotherapy Between Experienced and Inexperienced Breast Cancer Patients
J. Clin. Oncol., September 20, 2005; 23(27): 6623 - 6630.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Dosik
Withholding Information From Study Participants in Clinical Trials: Ethical Considerations
J. Clin. Oncol., July 1, 2005; 23(19): 4468 - 4469.
[Full Text] [PDF]

Home page
 JCOHome page
I. A. Olivotto, C. D. Bajdik, P. M. Ravdin, C. H. Speers, A. J. Coldman, B. D. Norris, G. J. Davis, S. K. Chia, and K. A. Gelmon
Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer
J. Clin. Oncol., April 20, 2005; 23(12): 2716 - 2725.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
T. J. Whelan and C. Loprinzi
Physician/Patient Decision Aids for Adjuvant Therapy
J. Clin. Oncol., March 10, 2005; 23(8): 1627 - 1630.
[Full Text] [PDF]

Home page
 JCOHome page
N. Hebert-Croteau, J. Brisson, J. Latreille, M. Rivard, N. Abdelaziz, and G. Martin
Compliance With Consensus Recommendations for Systemic Therapy Is Associated With Improved Survival of Women With Node-Negative Breast Cancer
J. Clin. Oncol., September 15, 2004; 22(18): 3685 - 3693.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. B. Benson III, D. Schrag, M. R. Somerfield, A. M. Cohen, A. T. Figueredo, P. J. Flynn, M. K. Krzyzanowska, J. Maroun, P. McAllister, E. Van Cutsem, et al.
American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
J. Clin. Oncol., August 15, 2004; 22(16): 3408 - 3419.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. J.T. Jansen, W. Otten, and A. M. Stiggelbout
Review of Determinants of Patients' Preferences for Adjuvant Therapy in Cancer
J. Clin. Oncol., August 1, 2004; 22(15): 3181 - 3190.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Gill, C. L. Loprinzi, D. J. Sargent, S. D. Thome, S. R. Alberts, D. G. Haller, J. Benedetti, G. Francini, L. E. Shepherd, J. Francois Seitz, et al.
Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?
J. Clin. Oncol., May 15, 2004; 22(10): 1797 - 1806.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. K. Chia, C. H. Speers, C. J. Bryce, M. M. Hayes, and I. A. Olivotto
Ten-Year Outcomes in a Population-Based Cohort of Node-Negative, Lymphatic, and Vascular Invasion-Negative Early Breast Cancers Without Adjuvant Systemic Therapies
J. Clin. Oncol., May 1, 2004; 22(9): 1630 - 1637.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. Chao, J. L. Studts, T. Abell, T. Hadley, L. Roetzer, S. Dineen, D. Lorenz, A. YoussefAgha, and K. M. McMasters
Adjuvant Chemotherapy for Breast Cancer: How Presentation of Recurrence Risk Influences Decision-Making
J. Clin. Oncol., December 1, 2003; 21(23): 4299 - 4305.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. A. Davol, R. Bagdasaryan, G. J. Elfenbein, A. L. Maizel, and A. R. Frackelton Jr.
Shc Proteins Are Strong, Independent Prognostic Markers for Both Node-Negative and Node-Positive Primary Breast Cancer
Cancer Res., October 15, 2003; 63(20): 6772 - 6783.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Goldhirsch, W. C. Wood, R. D. Gelber, A. S. Coates, B. Thurlimann, and H.-J. Senn
Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer
J. Clin. Oncol., September 1, 2003; 21(17): 3357 - 3365.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
T. P. Shakespeare, J. J. Lu, M. F. Back, S. Liang, R. K. Mukherjee, and C. J. Wynne
Patient Preference for Radiotherapy Fractionation Schedule in the Palliation of Painful Bone Metastases
J. Clin. Oncol., June 1, 2003; 21(11): 2156 - 2162.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
L. Pusztai, M. Ayers, J. Stec, and G. N. Hortobagyi
Clinical Application of cDNA Microarrays in Oncology
Oncologist, June 1, 2003; 8(3): 252 - 258.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. H. Lerner
First, You Cry, 25 Years Later
J. Clin. Oncol., May 1, 2003; 21(90090): 122s - 124.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
T. Whelan, C. Sawka, M. Levine, A. Gafni, L. Reyno, A. Willan, J. Julian, S. Dent, H. Abu-Zahra, E. Chouinard, et al.
Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer
J Natl Cancer Inst, April 16, 2003; 95(8): 581 - 587.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. Sonpavde
Communicating the Value of Adjuvant Chemotherapy
J. Clin. Oncol., March 1, 2003; 21(5): 948 - 949.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
K.-A. Phillips and J. Bernhard
Adjuvant Breast Cancer Treatment and Cognitive Function: Current Knowledge and Research Directions
J Natl Cancer Inst, February 5, 2003; 95(3): 190 - 197.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
T. Whelan
A Trial of Two Questions
J. Clin. Oncol., October 15, 2002; 20(20): 4135 - 4138.
[Full Text] [PDF]

Home page
 JCOHome page
N. Harbeck, R. E. Kates, and M. Schmitt
Clinical Relevance of Invasion Factors Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1 for Individualized Therapy Decisions in Primary Breast Cancer Is Greatest When Used in Combination
J. Clin. Oncol., February 15, 2002; 20(4): 1000 - 1007.
[Abstract] [Full Text] [PDF]

Home page
 J Natl Cancer Inst MonogrHome page
R. J. Simes and A. S. Coates
Patient Preferences for Adjuvant Chemotherapy of Early Breast Cancer: How Much Benefit Is Needed?
J Natl Cancer Inst Monographs, December 1, 2001; 2001(30): 146 - 152.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Goldhirsch, J. H. Glick, R. D. Gelber, A. S. Coates, and H.-J. Senn
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
J. Clin. Oncol., September 15, 2001; 19(18): 3817 - 3827.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
F. Janicke, A. Prechtl, C. Thomssen, N. Harbeck, C. Meisner, M. Untch, C. G. J. F. Sweep, H.-K. Selbmann, H. Graeff, and M. Schmitt
Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1
J Natl Cancer Inst, June 20, 2001; 93(12): 913 - 920.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. H. Lerner and B. Rollin
First, You Cry, 25 Years Later
J. Clin. Oncol., June 1, 2001; 19(11): 2967 - 2969.
[Full Text] [PDF]

Home page
 JCOHome page
A. B. Kornblith
Does Palliative Care Palliate?
J. Clin. Oncol., April 15, 2001; 19(8): 2111 - 2113.
[Full Text] [PDF]

Home page
 JCOHome page
N. Leighl, M. Gattellari, P. Butow, R. Brown, and M. H.N. Tattersall
Discussing Adjuvant Cancer Therapy
J. Clin. Oncol., March 15, 2001; 19(6): 1768 - 1778.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Recht, S. B. Edge, L. J. Solin, D. S. Robinson, A. Estabrook, R. E. Fine, G. F. Fleming, S. Formenti, C. Hudis, J. J. Kirshner, et al.
Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology
J. Clin. Oncol., March 1, 2001; 19(5): 1539 - 1569.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. J. Lee, D. Fairclough, J. H. Antin, and J. C. Weeks
Discrepancies Between Patient and Physician Estimates for the Success of Stem Cell Transplantation
JAMA, February 28, 2001; 285(8): 1034 - 1038.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. L. Loprinzi and S. D. Thome
Understanding the Utility of Adjuvant Systemic Therapy for Primary Breast Cancer
J. Clin. Oncol., February 15, 2001; 19(4): 972 - 979.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. M. Ravdin, L. A. Siminoff, G. J. Davis, M. B. Mercer, J. Hewlett, N. Gerson, and H. L. Parker
Computer Program to Assist in Making Decisions About Adjuvant Therapy for Women With Early Breast Cancer
J. Clin. Oncol., February 15, 2001; 19(4): 980 - 991.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
E. M. Cyran, L. A. Crane, and L. Palmer
Physician Sex and Other Factors Associated With Type of Breast Cancer Surgery in Older Women
Arch Surg, February 1, 2001; 136(2): 185 - 191.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. E. Lippman and D. F. Hayes
Adjuvant Therapy for All Patients With Breast Cancer?
J Natl Cancer Inst, January 17, 2001; 93(2): 80 - 82.
[Full Text] [PDF]

Home page
 JAMAHome page
J. Mandelblatt, K. R. Yabroff, W. Lawrence, B. Yi, G. Orosz, H. G. Bloom, C. B. Schecther, M. Extermann, L. Balducci, W. Satadano, et al.
Screening Mammography in Elderly Women
JAMA, June 28, 2000; 283(24): 3202 - 3204.
[Full Text] [PDF]

Home page
 JAMAHome page
M. Morrow and S. J. Schnitt
Treatment Selection in Ductal Carcinoma In Situ
JAMA, January 26, 2000; 283(4): 453 - 455.
[Full Text] [PDF]

Home page
 CMAJHome page
N. Hebert-Croteau, J. Brisson, J. Latreille, C. Blanchette, and L. Deschenes
Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994
Can. Med. Assoc. J., October 1, 1999; 161(8): 951 - 955.
[Abstract] [Full Text] [PDF]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 1998 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online